Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A virtual scalable model of the Hepatic Lobule for acetaminophen hepatotoxicity prediction.
Camara Dit Pinto S, Cherkaoui J, Ghosh D, Cazaubon V, Benzeroual KE, Levine SM, Cherkaoui M, Sood GK, Anandasabapathy S, Dhingra S, Vierling JM, Gallo NR. Camara Dit Pinto S, et al. Among authors: vierling jm. NPJ Digit Med. 2024 Nov 28;7(1):340. doi: 10.1038/s41746-024-01349-5. NPJ Digit Med. 2024. PMID: 39604584 Free PMC article.
Lessons From COBALT: Will the Bell Also Toll for Thee?
Vierling JM, Pockros PJ. Vierling JM, et al. Am J Gastroenterol. 2024 Oct 2. doi: 10.14309/ajg.0000000000003061. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39356113 No abstract available.
Primary biliary cholangitis.
Tanaka A, Ma X, Takahashi A, Vierling JM. Tanaka A, et al. Among authors: vierling jm. Lancet. 2024 Sep 14;404(10457):1053-1066. doi: 10.1016/S0140-6736(24)01303-5. Epub 2024 Aug 28. Lancet. 2024. PMID: 39216494 Free article. Review.
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).
Clark VC, Strange C, Strnad P, Sanchez AJ, Kwo P, Pereira VM, van Hoek B, Barjaktarevic I, Corsico AG, Pons M, Goldklang M, Gray M, Kuhn B, Vargas HE, Vierling JM, Vuppalanchi R, Brantly M, Kappe N, Chang T, Schluep T, Zhou R, Hamilton J, San Martin J, Loomba R. Clark VC, et al. Among authors: vierling jm. Gastroenterology. 2024 Oct;167(5):1008-1018.e5. doi: 10.1053/j.gastro.2024.06.028. Epub 2024 Jul 2. Gastroenterology. 2024. PMID: 38964420 Free article. Clinical Trial.
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladrón de Guevara Cetina AL, Janczewska E, Zigmond E, Jeong SH, Yilmaz Y, Kallis Y, Corpechot C, Buggisch P, Invernizzi P, Londoño Hurtado MC, Bergheanu S, Yang K, Choi YJ, Crittenden DB, McWherter CA; RESPONSE Study Group. Hirschfield GM, et al. Among authors: vierling jm. N Engl J Med. 2024 Feb 29;390(9):783-794. doi: 10.1056/NEJMoa2312100. Epub 2024 Feb 21. N Engl J Med. 2024. PMID: 38381664 Clinical Trial.
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy.
Cohen EB, Regev A, Garg A, Di Bisceglie AM, Lewis JH, Vierling JM, Hey-Hadavi J, Steplewski K, Fettiplace A, Chen CL, Pehlivanov N, Kendrick S, I Avigan M. Cohen EB, et al. Among authors: vierling jm. Drug Saf. 2024 Apr;47(4):321-332. doi: 10.1007/s40264-024-01399-4. Epub 2024 Feb 14. Drug Saf. 2024. PMID: 38353882 Free PMC article.
215 results